We are excited to share that RebrAIn has been featured by ActuIA for our innovative work in neurosurgical targeting for Deep Brain Stimulation (DBS).
The article highlights our supervised AI-driven solutions that significantly improve patient outcomes for those with Parkinson’s Disease and Essential Tremor. Founded by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, RebrAIn is transforming the landscape of neurosurgery with our precise and effective treatments.
Read the full article, “Focus on RebrAIn, the start-up that aims to revolutionize the surgical targeting of Deep Brain Stimulation”, in French on actuia.com here.
An English translation by Google is available here.